City

Boston (1)

Denison (1)

Louisville (1)

Philadelphia (1)

Phoenix (1)

Reno (1)

Sacramento (1)

Savannah (1)

Condition

Retina Vein Occlusion (3)

Age-related Macular Degeneration (1)

Diabetic Macular Edema (1)

Diabetic Retinopathy (1)

Diabetic Vascular Diseases (1)

Hereditary Macular Degeneration (1)

Non-exudative Age-related Macular Degeneration (1)

Proliferative Retinopathy (1)

Retinitis Pigmentosa (1)

Overall Status

Completed (1)

Enrolling by invitation (1)

Unknown status (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

phase 2 (1)

Sponsor

Graybug Vision (1)

MidAtlantic Retina (1)

University of California, Davis (1)

Collaborator

Intervention

cd34+ bone marrow stem cells intravitreal (1)

chlorhexidine (1)

gb-102 (1)

povidine-iodine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

retina vein occlusion

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion Trial in Sacramento (CD34+ bone

Enrolling by invitation

Non-exudative Age-related Macular Degeneration
+4 more

CD34+ bone marrow stem cells intravitreal

Sacramento, California

University of California Davis

Aug 8, 2022

Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)

Completed

Diabetic Macular Edema
Retina Vein Occlusion

GB-102

Phoenix, Arizona
+5 more

Nov 18, 2021

Age-related Macular Degeneration, Diabetic Vascular Diseases, Proliferative Retinopathy Trial in Philadelphia (Chlorhexidine,

Unknown status

Age-related Macular Degeneration
+3 more

Philadelphia, Pennsylvania

MidAtlantic Retina

Jun 25, 2018